Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Fgf20 is important for the development and regulation of the cells that form the base of hair follicles.

Aging changes hair stem cells and their environment, leading to gray hair and hair thinning, but understanding these changes could help develop treatments for hair regeneration.

Treating stubborn hair loss involves both medical and emotional support options.

STAT5 is crucial for hair growth in 3D cultured human dermal papilla cells.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

The research found that a specific skin cell type not only triggers hair growth but also controls hair color, and that aging can lead to hair loss and color changes.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

Researchers created human hair follicles using a new method that could help treat hair loss.

10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.

Cyclosporine may cause hair loss, so patients need monitoring.

The method can test hair growth products using a lab-made hair-like structure that responds to known treatments.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

JAK inhibitors offer new hope for treating severe alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Hair loss requires customized treatments based on its various causes and types.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

People with alopecia areata may have a higher risk of blood clots.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.